Patents by Inventor Xiaoling ZENG

Xiaoling ZENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240010680
    Abstract: A peptide disinfectant for preventing coronaviruses is provided. The peptide disinfectant for preventing coronaviruses comprises an active ingredient of the peptide disinfectant comprises mixed peptides comprising a first peptide (SEQ ID NO. 01), a second peptide (SEQ ID NO. 02), and a third peptide (SEQ ID NO. 03).
    Type: Application
    Filed: July 12, 2023
    Publication date: January 11, 2024
    Inventors: Chimeng TZENG, Minhuang HU, Xueting WANG, Bingyi ZHENG, Caiying ZENG, Xiaoling ZENG
  • Publication number: 20210357678
    Abstract: An information processing method and apparatus, and a storage medium, the method including: on the basis of aggregated archive data, determining a target object; acquiring first capture image information of the target object; analysing the first capture information to obtain a first analysis result; and, on the basis of the first analysis result, determining a first trajectory of the target object.
    Type: Application
    Filed: July 27, 2021
    Publication date: November 18, 2021
    Inventors: Xiaotong LI, Yiren ZENG, Xuyang YAN, Xiaoling ZENG, Tong GUO
  • Patent number: 10751371
    Abstract: Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: August 25, 2020
    Assignees: Cellular Biomedicine Group (Shanghai) Ltd., Cellular Biomedicine Group (Wuxi) Ltd.
    Inventors: Wei Cao, Xiaoling Zeng, Mohammad Abdul Kaium, Yujie Zhou
  • Publication number: 20180296605
    Abstract: Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
    Type: Application
    Filed: April 6, 2018
    Publication date: October 18, 2018
    Inventors: Wei CAO, Xiaoling ZENG, Mohammad Abdul KAIUM, Yujie ZHOU
  • Patent number: 9956250
    Abstract: Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: May 1, 2018
    Assignees: Cellular Biomedicine Group (Shanghai) Ltd, Cellular Biomedicine Group (Wuxi) Ltd.
    Inventors: Wei Cao, Xiaoling Zeng, Mohammad Abdul Kaium, Yujie Zhou
  • Publication number: 20160000830
    Abstract: Provided are uses of allogeneic interstitial vessel-layer cells and allogeneic mesenchymal progenitor cells in the preparation of a pharmaceutical composition for preventing or treating osteoarthritis (OA). Also provided is a pharmaceutical composition containing the allogeneic interstitial vessel-layer cells and the allogeneic mesenchymal progenitor cells.
    Type: Application
    Filed: January 28, 2014
    Publication date: January 7, 2016
    Inventors: Wei CAO, Xiaoling ZENG, Mohammad Abdul KAIUM, Yujie ZHOU